Breaking News
1 day ago
Vaibhavi M.

Medera adds three cardiopulmonary specialists to its SAB as SRD-002, its intracoronary AAV HFpEF gene therapy, approaches its next clinical milestone.
Vaibhavi M.

Abbott's Healthy Food Rx study shows medication adherence rose from 57% to 94% when food boxes were paired with community health worker coaching.
Vaibhavi M.
Optimi Health begins GMP ibogaine finished drug development in BC, targeting clinical trial supply as FDA accelerates psychedelic review.
Vaibhavi M.

Roche's $2.3B deal for BTK degrader bexobrutideg raises process validation and GMP complexity questions for CMOs and QA teams.
Vaibhavi M.
